{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T04:57:10Z","timestamp":1788238630642,"version":"build-2803163510"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"vor","delay-in-days":44,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"University Hospital Kralovske Vinohrady, Prague","award":["IG2021"],"award-info":[{"award-number":["IG2021"]}]},{"name":"COOPERATIO 33 Intensive Care Medicine, Charles University"},{"name":"RECETOX Research Infrastructure","award":["LM2023069"],"award-info":[{"award-number":["LM2023069"]}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","award":["857560"],"award-info":[{"award-number":["857560"]}],"id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016366","name":"General University Hospital in Prague","doi-asserted-by":"crossref","award":["RVO VFN 64165"],"award-info":[{"award-number":["RVO VFN 64165"]}],"id":[{"id":"10.13039\/501100016366","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To assess early identification of infectious complications in pediatric burn patients and to evaluate the performance of the Intensive Care Infection Score (ICIS) in comparison with conventional inflammatory biomarkers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Prospective observational cohort study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Tertiary pediatric burn intensive care unit.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients<\/jats:title>\n                    <jats:p>Children admitted within 24\u00a0h of acute burn injury and requiring intensive care for \u2265\u20093 days.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions<\/jats:title>\n                    <jats:p>None.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Measurements and main results<\/jats:title>\n                    <jats:p>Sixty-nine children were enrolled; 18 (26%) experienced at least one infectious episode. Infection was defined using a composite reference standard that included clinical diagnosis, microbiological findings, and initiation of targeted antibiotic therapy. ICIS was calculated from extended complete blood count parameters obtained during routine clinical care. Receiver operating characteristic analysis demonstrated higher discriminative performance of ICIS compared with C-reactive protein and procalcitonin in this cohort. The area under the curve for ICIS was 0.93, compared with 0.71 and 0.72 for C-reactive protein and procalcitonin, respectively. At a cutoff value of \u22654, ICIS demonstrated very high sensitivity and negative predictive value in this cohort, with no false-negative observations, and a specificity of 0.70.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In pediatric burn patients, ICIS demonstrated high diagnostic accuracy in this cohort and improved discrimination compared with C-reactive protein and procalcitonin, particularly as a rule-out test. These findings provide novel evidence on the application of ICIS in a pediatric burn population. As ICIS is derived from routine blood counts without additional sampling or direct laboratory cost, it may represent a practical tool to support early clinical decision-making and antimicrobial stewardship in pediatric burn care.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12887-026-06867-7","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T02:06:15Z","timestamp":1776650775000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Early identification of infectious complications in pediatric burn patients: a prospective cohort study"],"prefix":"10.1186","volume":"26","author":[{"given":"Bohumil","family":"Bakal\u00e1\u0159","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Zaj\u00ed\u010dek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Frejlach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e1clava","family":"Ad\u00e1mkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terezie","family":"Pol\u00e1\u010dkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra Bo\u0159ilov\u00e1","family":"Linhartov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Fridrichov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena Lahoda","family":"Brodsk\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,20]]},"reference":[{"key":"6867_CR1","doi-asserted-by":"crossref","unstructured":"Korzeniowski T, Mertowska P, Mertowski S, Podgajna M, Grywalska E, Struzyna J, Torres K. The Role of the Immune System in Pediatric Burns: A Systematic Review. J Clin Med. 2022;11(8):2262.","DOI":"10.3390\/jcm11082262"},{"issue":"4","key":"6867_CR2","doi-asserted-by":"publisher","first-page":"472","DOI":"10.5935\/0103-507X.20160080","volume":"28","author":"VS Lanziotti","year":"2016","unstructured":"Lanziotti VS, Povoa P, Soares M, Silva JR, Barbosa AP, Salluh JI. Use of biomarkers in pediatric sepsis: literature review. Rev Bras Ter Intensiva. 2016;28(4):472\u201382.","journal-title":"Rev Bras Ter Intensiva"},{"key":"6867_CR3","doi-asserted-by":"publisher","first-page":"957","DOI":"10.3389\/fimmu.2017.00957","volume":"8","author":"A Georgountzou","year":"2017","unstructured":"Georgountzou A, Papadopoulos NG. Postnatal Innate Immune Development: From Birth to Adulthood. Front Immunol. 2017;8:957.","journal-title":"Front Immunol"},{"issue":"3","key":"6867_CR4","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1177\/0300060514557711","volume":"43","author":"K Weimann","year":"2015","unstructured":"Weimann K, Zimmermann M, Spies CD, Wernecke KD, Vicherek O, Nachtigall I, Tafelski S, Weimann A. Intensive Care Infection Score\u2013A new approach to distinguish between infectious and noninfectious processes in intensive care and medicosurgical patients. J Int Med Res. 2015;43(3):435\u201351.","journal-title":"J Int Med Res"},{"issue":"1","key":"6867_CR5","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s40635-025-00767-3","volume":"13","author":"E Deniz","year":"2025","unstructured":"Deniz E, Klatte S, Tekin-Bubenheim N, Zimmermann M. Intensive care infection score: ICIS discriminates between infected and uninfected critically ill patients in routine intensive care unit practice. Intensive Care Med Exp. 2025;13(1):58.","journal-title":"Intensive Care Med Exp"},{"key":"6867_CR6","doi-asserted-by":"crossref","unstructured":"van der Geest PJ, Mohseni M, Linssen J, Duran S, de Jonge R, Groeneveld ABJ. The intensive care infection score \u2013 a novel marker for the prediction of infection and its severity. Crit Care. 2016;20(1):180.","DOI":"10.1186\/s13054-016-1366-6"},{"issue":"2","key":"6867_CR7","doi-asserted-by":"publisher","first-page":"109","DOI":"10.2174\/187152812800392841","volume":"11","author":"A Nierhaus","year":"2012","unstructured":"Nierhaus A, Linssen J, Wichmann D, Braune S, Kluge S. Use of a weighted, automated analysis of the differential blood count to differentiate sepsis from non-infectious systemic inflammation: the intensive care infection score (ICIS). Inflamm Allergy Drug Targets. 2012;11(2):109\u201315.","journal-title":"Inflamm Allergy Drug Targets"},{"key":"6867_CR8","doi-asserted-by":"crossref","unstructured":"Vrback\u00fd F, Bla\u017eek M, F\u00e1torov\u00e1 I, \u0160\u00edmov\u00e1 K, \u017d\u00e1k P. Intensive Care Infection Score (ICIS) is an Early Marker for Infection in Time of Admission to Intensive Care Units.Int J Lab Hematol. 2025;47(4):707\u2013712.","DOI":"10.1111\/ijlh.14468"},{"issue":"1","key":"6867_CR9","first-page":"36","volume":"113","author":"MT Rosanova","year":"2015","unstructured":"Rosanova MT, Tramonti N, Taicz M, Martiren S, Bas\u00edlico H, Signorelli C, Buchovsky A, Lede R. Assessment of C-reactive protein and procalcitonin levels to predict infection and mortality in burn children. Arch Argent Pediatr. 2015;113(1):36\u201341.","journal-title":"Arch Argent Pediatr"},{"key":"6867_CR10","doi-asserted-by":"publisher","first-page":"tkae080","DOI":"10.1093\/burnst\/tkae080","volume":"13","author":"TL Palmieri","year":"2025","unstructured":"Palmieri TL, Heard J. Biomarkers of sepsis in burn injury: an update. Burns Trauma. 2025;13:tkae080.","journal-title":"Burns Trauma"},{"key":"6867_CR11","doi-asserted-by":"crossref","unstructured":"Sepsis TABACCB, Group I, Greenhalgh DG, Saffle JR, Holmes JH, Gamelli IV, Palmieri RL, Horton TL, Tompkins JW, Traber RG et al. DL : American Burn Association Consensus Conference to Define Sepsis and Infection in Burns. Journal of Burn Care & Research. 2007;28(6):776\u2013790.","DOI":"10.1097\/BCR.0b013e3181599bc9"},{"issue":"1","key":"6867_CR12","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1089\/sur.2020.297","volume":"22","author":"LE Meza-Escobar","year":"2021","unstructured":"Meza-Escobar LE, Rehou S, Jeschke MG. Sepsis Definitions in Burns. Surg Infect (Larchmt). 2021;22(1):28\u201336.","journal-title":"Surg Infect (Larchmt)"},{"issue":"8","key":"6867_CR13","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1001\/jama.2024.0179","volume":"331","author":"LJ Schlapbach","year":"2024","unstructured":"Schlapbach LJ, Watson RS, Sorce LR, Argent AC, Menon K, Hall MW, Akech S, Albers DJ, Alpern ER, Balamuth F, et al. International Consensus Criteria for Pediatric Sepsis and Septic Shock. JAMA. 2024;331(8):665\u201374.","journal-title":"JAMA"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-026-06867-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-026-06867-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-026-06867-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:23:23Z","timestamp":1781648603000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12887-026-06867-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,20]]},"references-count":13,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6867"],"URL":"https:\/\/doi.org\/10.1186\/s12887-026-06867-7","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,20]]},"assertion":[{"value":"14 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the ethical standards of the responsible institutional committee on human experimentation and with the Declaration of Helsinki (1975, as revised). The protocol was approved by the Ethical Review Board of University Hospital Kr\u00e1lovsk\u00e9 Vinohrady, Prague, Czech Republic, on February 3, 2021 (approval No. EK-VP\/04101202). The trial was registered at ClinicalTrials.gov (ID NCT04894500) on May 16, 2021.Written informed consent was obtained prospectively from the legal representatives of all participating children.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"511"}}